Table 4.
Univariate and multivariate analyses of factors associated with clinical efficacy in 190 patients who attempted refeeding after successful endoscopic ultrasound-guided gastroenterostomy or enteral stenting.
| Variables | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| Clinical Efficacy Yes/No |
p Value | p Value | OR (95% CI) | |
| Age <65 >65 |
62/13 99/16 |
0.541 |
- |
|
| Gender Male Female |
73/17 88/12 |
0.227 |
- |
|
| Type of malignancy Pancreatic Other |
117/22 44/7 |
0.822 |
- |
|
| Stage of disease Resectable/locally advanced Metastatic |
86/12 75/17 |
0.460 |
- |
|
| Biliary obstruction Yes No |
96/25 65/4 |
0.006 |
0.052 |
3.07 (0.99–9.53) |
| Stenosis location * Type I Type II Type III |
55/11 66/13 40/5 |
0.674 |
- |
|
| PS ECOG 0–1 2–4 |
80/6 81/23 |
0.004 |
0.034 |
2.87 (1.08–7.63) |
| Endoscopic treatment EUS-GE ES |
60/3 101/26 |
0.004 |
0.056 |
3.44 (0.96–12.25) |
EUS-GE: endoscopic ultrasound-guided gastroenterostomy; ES: enteral stenting; SD: standard deviation; PS-ECOG: Eastern Cooperative Oncology Group performance status. * According to the Mutignani classification [26].